small molecule

MYCELEX

CLOTRIMAZOLE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameMYCELEX
Active ingredientCLOTRIMAZOLE
Strength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTROCHE/LOZENGE
RouteORAL
ModalitySmall molecule
FDA approvalJune 1983
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.